Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Feb 2006 07:00 AM
RNS
Notice of Results
03 Feb 2006 09:48 AM
RNS
Board Appointment
26 Jan 2006 09:46 AM
RNS
Holding(s) in Company
24 Jan 2006 08:44 AM
RNS
Holding(s) in Company
18 Jan 2006 04:13 PM
RNS
Viragen Milestone
04 Jan 2006 10:12 AM
RNS
Holding(s) in Company
20 Dec 2005 04:42 PM
RNS
Holding(s) in Company
19 Dec 2005 05:10 PM
RNS
Holding in Company Correction
19 Dec 2005 04:55 PM
RNS
Holding(s) in Company
19 Dec 2005 11:07 AM
RNS
Holding(s) in Company
16 Dec 2005 01:45 PM
RNS
Director/PDMR S/hldg-Amend
16 Dec 2005 08:23 AM
RNS
Director/PDMR Shareholding
15 Dec 2005 09:00 AM
RNS
Director/PDMR Shareholding
12 Dec 2005 12:34 PM
RNS
Holding(s) in Company
12 Dec 2005 11:24 AM
RNS
Result of EGM
09 Dec 2005 11:43 AM
RNS
Holding(s) in Company
08 Dec 2005 03:31 PM
RNS
Holding(s) in Company
24 Nov 2005 11:37 AM
RNS
Holding(s) in Company
22 Nov 2005 04:12 PM
RNS
Blocklisting Interim Review
22 Nov 2005 12:17 PM
RNS
Holding(s) in Company
22 Nov 2005 07:00 AM
RNS
TroVax Notice of Allowance
17 Nov 2005 09:35 AM
RNS
Holding(s) in Company
16 Nov 2005 04:20 PM
RNS
Publication of Prospectus
16 Nov 2005 07:01 AM
RNS
Phase II trial with TroVax
16 Nov 2005 07:01 AM
RNS
Placing and Open Offer
15 Nov 2005 11:54 AM
RNS
Holding(s) in Company
02 Nov 2005 02:22 PM
RNS
Trovax & Proposed Fundraising
24 Oct 2005 01:49 PM
RNS
Trovax Clarification
24 Oct 2005 07:00 AM
RNS
Licence Agreement
20 Oct 2005 07:00 AM
RNS
Agreement with Sigma-Aldrich
19 Oct 2005 07:00 AM
RNS
Wyeth Preclinical Data
18 Oct 2005 11:30 AM
RNS
Additional Phase II Data
17 Oct 2005 07:00 AM
RNS
Final Phase II Results
06 Oct 2005 07:00 AM
RNS
Prelim Phase II Results
03 Oct 2005 01:54 PM
RNS
Change of Adviser
28 Sep 2005 05:55 PM
RNS
Holding(s) in Company
20 Sep 2005 07:00 AM
RNS
Interim Results
16 Sep 2005 06:22 PM
RNS
Holding(s) in Company
07 Sep 2005 07:01 AM
RNS
Appointment
05 Sep 2005 07:00 AM
RNS
Notice of Results
25 Aug 2005 02:11 PM
RNS
Holding(s) in Company
18 Aug 2005 10:06 AM
RNS
Holding(s) in Company
17 Aug 2005 01:56 PM
RNS
Holding(s) in Company
01 Aug 2005 07:00 AM
RNS
Completion of Clinical Trial
25 Jul 2005 07:00 AM
RNS
Awarded Research Grant
06 Jul 2005 04:09 PM
RNS
Holding(s) in Company
04 Jul 2005 07:00 AM
RNS
Two New Patents Granted
30 Jun 2005 04:00 PM
RNS
Holding(s) in Company
29 Jun 2005 04:00 PM
RNS
Holding(s) in Company
17 Jun 2005 03:21 PM
RNS
Holding(s) in Company

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings